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Introduction
Retinoblastoma (RB) is the most prevalent intraocular 
malignancy that commonly affects children <3 years of 
age, but may also appear at>5 years of age [1, 2]. This 
malignancy can end up with blindness or death if not 
diagnosed early. The RB incidence varies according to 
the sociodemographics of each country [3-5] Parental 
education, low socioeconomic conditions, and inadequate 
health facilities may result in delays of diagnosis and 
management of RB in developing countries. In developed 
countries such as America, Britain, and other European 
countries, this malignancy is diagnosed earlier in 
childhood <2 years [6].
The RB incidence is 1: 15.000-20.000 per birth rate. 
This cancer generally occurred unilaterally, the mean 
age when diagnosed was two years in 60% of cases [4].
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The World Health Organization (WHO), in 18 February 
1999, promoted The Right to Sight program to eliminate 
childhood blindness so that childhood blindness rates 
would decline by 2020 [5].
In developed countries with high levels of 
community education, optimal health facilities, and 
good socioeconomic conditions; RB was diagnosed with 
early clinical manifestations. In these countries patients 
generally come with intraocular tumor manifestation with 
clinical manifestations of cat eye (leukokoria), strabismus, 
and decrease of vision [7]. In developing countries, 
however, 60-90% patients come with extraocular tumor 
manifestation with clinical manifestations of prominent 
eye (proptosis), orbital cellulitis, corneal perforation, and 
stem mass [8].
The RB classification affects preliminary management, 
outcome prediction, and prognose [9]. The first RB 
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classification of Reese-Ellsworth (1950) transformed 
into the International Intraocular Retinoblasma (IIRC) 
classification (2003) that emphasized chemotherapy and 
focal lasers, and provided better treatment outcomes.
(Deng,2013) This increase in the  therapeutic success rate, 
and visual outcome of patients improved significantly in 
developed countries compared to developing countries 
[10] The therapeutic success rate and visual outcome 
of patients in developing countries are low due to late 
diagnosis along with poor clinical conditions when 
patients are treated [11].
The tertiary hospital in Medan, Indonesia, covered 
a remote area. As a consequence, most RB patients 
were in the advanced stage of their condition. The 
purpose of this study is to report clinical characteristics 
and demographics, of retinoblastoma patients, from 
a tertiary hospital covering a remote area in a developing 
country.
Materials and Methods
This is a descriptive study using total samplings. 
The population and sample of this study were all patients 
who were diagnosed with retinoblastoma at Adam Malik 
Hospital, Medan, January 2011 to December 2016. 
The data was obtained from medical records of RB 
patients. The North Sumatera University Institutional 
Ethics Committee granted approval for this study 
following the tenets of the Declaration of Helsinki. 
Patients without treatment were not included in the study.
Torch or slit lamp examination (if possible) was done 
carefully to look for any significant anterior segment 
findings. Initial and final visual acuity, and eye movement 
were checked during this examination. Any extra ocular 
findings were recorded. The pupil was dilated with 
tropicamide 0,5% ED, dropped twice in 5 minutes 
intervals. The funduscopic examination was done, and any 
findings were drawn on medical record. The therapeutic 
management was recorded. The therapeutic management 
was surgery, chemotherapy, radiotherapy or a combination; 
and the outcomes were recorded.
Sociodemographics of the elderly were listed in the 
medical record and grouped as lower, middle, and upper 
class. The nutritional status was assessed from the body 
mass index or the surface area of the body listed in the 
medical record.The nutritional status was classified 
into three categories namely, malnourished, normal, or 
obese. The severity was the order of severity of an illness 
based on the criteria using the RBD Resse-Ellsworth 
classification. The clinical symptoms are characteristic 
symptoms that appeared and include the doctor’s diagnosis 
and parents’ complaint as written in the medical record. 
The onset was the duration of clinical symptoms that 
appeared until the child was taken by his/her parents to 
the doctor.  The outcome was the final result that describes 
the level of success of the management. In this study, we 
determined to follow up at least 1 week after therapy since 
almost all patients had follow-up 1 week then back to the 
remote are, and recorded whether the patient lived or died. 
All patients were included in analysis. SPSS version 24.0 
(SPSS, Inc., Chicago, IL) was used.
Result
There were 129 new cases of retinoblastoma 
coming to Adam Malik Hospital Medan during the period 
of January 2011 - December 2016. A total of 91 patients 
met the inclusion criteria, while the other 38 patients were 
not eligible because of incomplete medical record data. 
These eligible patients came from remote areas.
Distribution of patients per year for 5 years was 
relatively even (between 12 - 23%), with distribution 
14 patients (15.4%) in 2011, 11 patients (12.1%) in 2012, 
21 patients (23.1%) in2013, 17 patients (18.7%) in 2014, 
12 patients (13.25) in 2015, and 12 patients (13.2%) 
in 2016. The frequencies in 2013 were higher, but cannot 
be explained because there was no further information in 
the medical record.
Based on sociodemographic data, the frequency was 
even between 45 middle income  patients (49.5%) and 46 
lower middle income patients (50.5%). The mean age at 
diagnosis was 3-5 year for 49 patients (53.8%), ranging 
from 1 to 12 years. Male to female ratio was 1:1.
The majority of the 64 patients (70.3%) suffered 
maltnutrion. There was no family history of RB, and 
all cases occurred unilaterally. The laterality was equal 
between right or left eye, with 1:1 ratio. The majority 
of the patients presenting with extra ocular involvement 
was 73 patients (80.2%) while the clinical symptom of 
protruded eye was 70 patients (76.9%). Patients generally 
presented in stage IV of 70 cases (76.9%). The mean 
onset was 1-2 years in 43 cases (47.2%). The therapeutic 
management was the chemotherapy method of Vincristine 
(VCR), Etoposide (EPO), Carboplatin (CPA) in  39 cases 
(42,9%). The patient’s
outcome was measured as still living in 89 cases 
(97.8%) after following up at a minimum of one week. 
After the treatment, all patients followed up in less than 
two weeks, they return back to remote area. Details are 
shown in Table 1.
The patients with onset <1 year mainly presented with 
the intra ocular clinical symptom of  cat eye: 13 patients 
(21.9%). Patients with onset >1 year presented as extra 
ocular cases with the clinical symptom of protruded 
eye in 28-29 patients. There is no record of tumors size 
and fundus photo was not done as a tool to perform 
documentation, so details of the tumor are difficult to 
obtain.
The longer the onset, the more severe were the 
appearances of the clinical symptoms. None of the cases 
underwent evisceration or enucleation because of the late 
stage of the tumors and the parents refused the treatment 
because they feared facing their child’s disfiguration 
without an eye. Details are shown in Table 2.
Discussion
This is a descriptive study to report the characteristics 
of retinoblastoma patients at Adam Malik Hospital Medan 
from January 2011 to December 2016. There were 129 
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The same conditions are found in Indonesia. In this study 
patients presented at an older age and sociodemographic 
background. There was no difference between middle and 
lower middle class patients.
In this study, more patients fell into the malnourished 
category at 64 patients (70.3%). The patients with solid 
tumors have an increase in basal metabolic rates of up to 
50% and this is related to decreased nutritional status and 
the type and size of tumors. In patients with solid tumors, 
major changes occured in fat metabolism followed by 
weight loss, largely due to the depletion of body fat [12].
Compared with adults, children have a greater risk of 
nutritional deficiencies due to their faster basal metabolics 
associated with growth and development.This contributes 
to the deterioration of the patient’s nutritional status in 
this study [13].
In this study, there were 47 male patients (51.6%) and 
44 female patients (48.4%). A study of Soetomo Hospital 
(2010), Surabaya, Indonesia also reported no gender 
difference in RB disease [14], but the other study at the 
same place [15] found more males at 27 (61.3%), and 
than  women at 17 (38.6%). In general, the ratio of men to 
women with retinoblastoma is unknown [16]Other studies 
reported that there is no racial or gender predisposition to 
the incidence of retinoblastoma [8]. This malignancy is 
more commonly found and acquired (94%), as opposed 
to hereditary (6%). Knudson (1971) states that RB occurs 
due to mutations of two chromosomes: the germinal 
chromosome and the somatic chromosome. In hereditary 
RB, the initial mutation of germinal chromosomes is found 
throughout the cell, and a second mutation of somatic 
chromosomes occurred in retinal cells. In the  acquired RB, 
the two mutations derived from somatic cells [2, 8]. In this 
study, all cases were acquired RB, with no family history. 
There is no record of tumors size and fundus photos were 
not done as a tool to perform documentation, so details of 
the tumor are difficult to obtain. Documentation of tumor 
size or comparing with an optic nerve head unfortunately 
was not done.
Retinoblastoma was reported more frequently 
unilaterally sporadic (60%) rather than bilaterally 
hereditary (40%) [17, 18] Patients with bilateral 
retinoblastoma are assumed to have germinal cell 
mutations (100% hereditary), although genetic testing 
cannot identify these cell mutations (encountered 
in about 5% of cases). Hereditary (bilateral) RB was 
diagnosed at a younger mean age, 12-15 months; 
while acquired RB diagnosed at an older mean age, 24 
months [17]. In this study, all patients with unilateral 
retinoblastoma had a mean age of 42 months. The delay 
new patients of RB, 91 patients (91 eyes) fulfilling the 
inclusion criteria, while 38 patients were excluded because 
of incomplete data.
The RB incidence varies according to the 
sociodemographics of each country. In this study, 
49 patients presented at 3-5 years of age (53.8%). 
There were 46 patients (50.5%) with parents of middle 
social status, and 45 patients (49.5%) with middle to low 
social status. In developed countries such as America, 
Britain, and other European countries, this malignancy 
is diagnosed earlier in childhood  less <2 years [5, 6]. 
In developing countries, RB is diagnosed in older children. 
Characteristic Number %
Social Status
     -lower 45 49.5
     -middle 46 50.5
     -upper 0 0
Age (year)
     <3 32 35.2
     3-5 49 53.8
     >5 10 11
Nutritional status
     less 64 70.3
     normal 27 29.7
     obese 0 0
Tumor growth
     intraocular 18 19.8
     extraocular 73 80.2
     mix 0 0
Severity:
     stadium 1 20 22
     stadium 2 0 0
     stadium 3 1 1.1
     stadium 4 70 76.9
Prominent clinical sign 
     cat eye 20 22
     swelling 1 1.1
     protruded eye 70 76.9
Therapy
     Bone Marrow Puncture 15 16.5
     Exenteration 1 1.1
     Enucleation 22 24.2
     Chemmotherapy CPA 1 1.1
     Chemotherapy CPA/EPO 11 12.1
     Chemotherapy MTX 1 1.1
     Chemotherapy VCR/CPA 1 1.1
     Chemotherapy VCR/CPA/EPO 39 42.9
Outcome
     live 89 97.8
     death 2 2.2
Tabel 1. Demography and Clinical Characteristic of 
Retinoblastoma, Adam Malik Hospital Medan
Onset (year) Cat Eye Protruded Eye Total
<1 13 7 20
1-2 7 28 35
2-3 0 29 29
>3 1 6 7
21 70 91
Table 2. Onset Distribution by Age with Clinical Signs
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was related to the sociodemographic background of the 
patient’s parents and that of the patient’s origin from 
a remote area. Even if the patient presented late, there 
is inadequate management.  For example there is no 
documentation whether there is a reduction of the tumor 
or proptosis after treatment. Economic conditions make 
it difficult for patients and parents to stay in big cities. 
They return to the remote area soon after the treatment is 
completed, expecting further follow-up to be done in the 
remote area without any ophthalmologist and equipment.
In this study, more patients presented with extraocular 
clinical features (80.2%), with clinical manifestation 
proptosis in 70 patients (76.9%), in stage IV. In developed 
countries, patients generally present with intraocular 
tumor, [5, 7] with clinical manifestations of cat eye 
(leukokoria), strabismus, and decrease of vision whereas, 
in developing countries, 60-90% of patients come with 
extraocular clinical features,with clinical manifestations 
of proptosis, orbital cellulitis, corneal perforation, and 
stem mass [8, 17]. In this study, patients with extraocular 
clinical features were associated with delayed diagnosis 
with an  onset of 1-2 years at 43 people (47.2%). A similar 
clinical picture was reported by [14], in which patients 
came in withextraocular clinical features (60%) at 6-12 
months onset (25%).This  occurred due to limited access 
to adequate health facilities, lack of education and the 
parent’s socioeconomical situation. Since all these 
cases were already in an advance stage with a very poor 
prognosis, it can be presumed that these patients were less 
likely to follow-up because of death.
The RB Classification influences early management, 
outcome prediction, and prognosis. The first RB 
classification of Reese-Ellsworth (1950) predicts the 
outcome based on external-beam radiotherapy (EBRT); 
whereas, the International Intraocular Retinoblasma 
(IIRC) classification (2003) focuses on outcomes based on 
chemotherapy and focal lasers. Management of intraocular 
RB includes enucleation, chemotherapy, EBRT, and 
focal therapy (cryotherapy, laser photocoagulation, 
thermotherapy, brachytherapy I125). Based on IIRC, 
selected treatment of RB group B-D is using intravenous 
chemotherapy followed by focal therapy; whereas, the 
best treatment for unilateral RB group D is by enucleation 
[10, 19] The classification of RB used in Adam Malik 
Hospital Medan was unknown based on medical records; 
therefore, the main management reasons applied to the 
patient  are accordingly unknown. None of these cases 
underwent evisceration or enucleation because of the 
tumor’s late stage and the parents refusal due to their 
fear of facing their child’s condition without an eye. Low 
levels of economic status and education contributed to the 
parent’s refusal to accept explanations and make decisions 
to undergo surgery, and also because of the additional 
costs of surgery itself.
The therapeutic success rate and visual outcome of 
patients improved significantly in developed countries 
compared to developing countries. Chemotherapy 
followed by focal therapy has replaced the EBRT and 
provides a better outcome. However, the therapeutic 
success rate and visual outcome of patients in developing 
countries are low due to late diagnosis along with 
poor clinical conditions when patients are treated. 
[11, 12]. In this study, patients still alive is found in 
89 cases (97.8%). The therapeutic success rate in this 
study is quite high due to a short follow up in 1-2 weeks. 
This is because RB patients at RSUP Haji Adam Malik 
Medan come from a remote area, and the difficulty to visit 
even a primary health facility in town generally causes 
the patient fail to follow up. The life expectancy of the 
patients is an important indicator because they generally 
come in an advanced state and follow-up is limited to 
only 1-2 weeks. The drawback of this study is the lack 
of completeness of medical record data so that follow up 
can only be assessed briefly for 1-2 weeks, in addition to 
its retrospective study design resulting in improper data 
recording.
In conclusion, RB patients referred to a tertiary hospital 
in a remote area in Indonesia are more likely to come in 
an advanced stage. They were from middle-income group 
parents, and there were more extraocular cases with major 
clinical features of protruded eye at an onset 2-3 years.
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